Novel Method for Inducing Tissue Repair
Inventor(s)
Meenhard Herlyn and Mark Nesbit
Tech ID
HM96001
Key Words
dermatologic, Therapeutic, tissue engineering, wound healing
Applications and Advantages
Following simple injection, these viruses can induce the formation of either blood vessels (VEGF) or new stromal tissue (PDGF-B). The stimulation in vivo is self-limiting because the viruses are replication defective. These viruses may be useful for inducing wound healing and tissue repair in a variety of situations, including wound healing, reconstructive surgery and transplantation.
Intellectual Property Status
U.S. Patent No. 6,486,133.
Licensing Opportunity
Wistar is seeking an exclusive licensee and/or sponsored research to support the development of this technology.
